On Wednesday, October 17th, MJFF hosted the fifth event in its Hot Topics in PD Research Seminar Series: “Cognition and PD.” The webinar, which is now available on demand, was led by David Burn, MD, of Newcastle University, and Jamie Eberling, PhD, associate director of research programs at MJFF.
During the one-hour event, Burn and Eberling addressed the following topics:
- How cognitive impairment affects people with Parkinson’s disease (PD).
- How the drug development field is searching for new treatments in cognition.
- What people with PD can do today, both for themselves and to help drive forward research.
Burn and Eberling also covered a wide range of additional information about cognition and PD when they answered participant questions live. Stay tuned for Q&A blog post where Burn will answer more questions. And once you’ve checked out the webinar you can share your feedback on the session in this brief survey.
Those interested in learning more about cognitive impairment in PD can also access MJFF resources online. Read about an exciting partnership with pharmaceutical company Sanofi to develop a cognition-targeted drug, one family's journey with Parkinson's and dementia, and research suggesting a link between gait and cognitive decline.
To find out more about participating in clinical trials and see your own potential trial matches, visit www.foxtrialfinder.org.